Effect of propolis among frailty comorbid COPD patients

The requested reference [82d93970c79e4fcce78c938a49d6e19b32cc3cca] no longer exists in our database. It has been replaced by the current reference: [56d9ddcde95f8f3c6ab98f999aec162202111372]

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2018
INTERVENTION: Propolis 101.7mg X3 per day, everyday, for 3 month. Placebo 101.7mg X3 per day, everyday, for 3 month. CONDITION: COPD PRIMARY OUTCOME: Difference of frailty index before and after intake of propolis. SECONDARY OUTCOME: Socres of QOL,CAT,HADS,mMRC, and spirometry INCLUSION CRITERIA: COPD patients with frailty or pre‐frailty.
Epistemonikos ID: 190eaf612f961da5bb55043163aaf340d32ace2c
First added on: Aug 24, 2024